CINNOPAR
C.C.L (Pvt) Ltd.
CinnoPar® is a recombinant human parathyroid hormone analogproduced by CinnaGen Co. CinnoPar® is a prescription drug which is like natural hormone secreted by parathyroid glands called parathyroidhormone or PTH. Each pen contains 250 mcg/ml, 2.4 ml of teriparatide.
CinnoPar® stimulates bone formation, increases bone mineral density and bone strength. CinnoPar® can lessen the number of fractures of the spine and other bones in postmenopausal women with osteoporosis.
CinnoPar® is used in both men and postmenopausal women with osteoporosis who are at high risk for having fractures.
CinnoPar® can be used by people who have had a fracture related to osteoporosis, or who have multiple risk factors for fracture, or who cannot use other osteoporosis treatments.
Also, CinnoPar® is indicated for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture.